![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/14/2796008/0/en/GPCR-Therapeutics-Announces-Out-Licensing-Agreement-with-Bridge-Biotherapeutics-in-Idiopathic-Pulmonary-Fibrosis.html
https://www.globenewswire.com//news-release/2023/10/26/2767175/0/en/GPCR-Therapeutics-Announces-Publication-on-Improving-Hematopoietic-Stem-Cell-Mobilization-Using-Propranolol-with-GPC-100.html
https://www.globenewswire.com//news-release/2023/10/10/2757153/0/en/GPCR-Therapeutics-Expands-Pipeline-into-Fibrosis-with-a-Combination-Approach-Targeting-LPA1.html